-

-
近日,德國維爾茨堡大學生物中心生物技術與生物物理學系的研究人員在Science期刊上發表了一篇具有重要意義的論文,這項工作由歐洲研究委員會、德國聯邦教育和研究部以及德國研究基金會資助。該研究聚焦于治療性單克隆抗體(mAbs)與CD20分子之間的相互作用機制。這項研究不僅為理解mAbs如何激活免疫系統以殺死B細胞提供了關鍵的分子層面見解,還可能對改進現有mAbs藥物的設計和開發產生深遠影響。[查看]
-
http://m.baichuan365.com/Article/20250115_industrialnews_1.html
-

-
炎性體是介導caspase-1活化的多蛋白復合物, 它可以促進除了別的以外的促炎細胞因子白介素(IL)-1β和 IL-18的分泌物。nod樣受體家族的 NLRP3/NALP3是發危險信號到caspase-1活化炎性體的關鍵組成部分。NLRP3缺陷是導致家族性寒冷型自身炎癥綜合征1型(FCAS1)、Muckle-Wells 綜合征 (MWS) 和慢性炎癥性神經,皮膚,關節綜合征的原因。[查看]
-
http://m.baichuan365.com/Article/NLRP3_mab_1.html
-

-
Asc 促進半胱天冬酶介導的細胞凋亡。這種促凋亡活性主要通過半胱天冬酶-9 的活性介導。它是炎癥小體的一個組成部分,炎癥小體是包含 NLRP3/NALP3、CARD8 和 CASP1 的蛋白復合體,其功能是激活促炎性半胱氨酸蛋白酶。[查看]
-
http://m.baichuan365.com/Article/anti-Asc_pAb_1.html
-

-
人源化單抗技術是一種將鼠源單克隆抗體(McAb)通過基因工程手段改造為更接近人類抗體的結構,以降低其免疫原性并提高其臨床應用價值的技術。這項技術的發展經歷了多個階段,從最初的嵌合抗體到現代的全人源化單抗,技術不斷演進和完善。[查看]
-
http://m.baichuan365.com/Article/human_mab_1.html
-

-
熱休克蛋白 HSP70 家族包含 66-78 kDa 多種大小不等的同源物。HSP70 核苷酸與底物結合調節新合成的蛋白折疊,將折疊錯誤或變性的蛋白重新折疊,指揮跨膜蛋白的轉運,抑制蛋白質聚集,通過蛋白酶解途徑降解目標蛋白,從而在神經退行性疾病的發病機制中發揮著重要的作用,其功能和作用機制的進一步闡明則對治療和預防神經退行性疾病具有重要的意義。[查看]
-
http://m.baichuan365.com/Article/HSC70_pAb_1.html
-

-
除了常見的絲氨酸/蘇氨酸磷酸化的 Tau 蛋白已被證實與 Tau 蛋白病變相關外,雙螺旋絲也能與 Tau-pTyr 特異性抗體反應,表明酪氨酸磷酸化也存在于異常的 Tau 蛋白里。Enzo 提供一系列多克隆抗血清可以特異性識別酪氨酸磷酸化殘基,這對于研究正常或功能失常的 Tau 蛋白磷酸化機制具有重要意義。[查看]
-
http://m.baichuan365.com/Article/Tau_pab_1.html
-

-
麻省理工學院麥戈文腦研究所的科學家們通過對秀麗隱桿線蟲(Caenorhabditis elegans)的研究,揭開了一個長期存在的謎團,即控制細胞凋亡的因素:一種能夠防止程序性細胞死亡的蛋白質是如何促進細胞程序性死亡的。上個月,秀麗隱桿線蟲第四次獲得了諾貝爾獎。他們的研究由麻省理工學院David H. Koch生物學教授Robert Horvitz領導,并于10月9日在《Science Advances》雜志上發表,揭示了健康和疾病中細胞死亡的過程。[查看]
-
http://m.baichuan365.com/Article/mitnjtdjmlrkhdssdb_1.html
-

-
熊本大學的一組研究人員發現了導致神經退行性疾病(如帕金森病)的有害蛋白質聚集體形成的突破性機制。由Norifumi Shioda教授和Yasushi Yabuki副教授領導的研究小組首次發現,一種名為G-四重復合物(G4s)的獨特RNA結構在促進α-突觸核蛋白(一種與神經變性相關的蛋白質)的聚集中起著核心作用。通過證明抑制G4組裝可能潛在地阻止突觸核蛋白病的發生,這一發現將G4定位為這些疾病早期干預的有希望的靶點。[查看]
-
http://m.baichuan365.com/Article/cellypjsbxgddbzjjdxj_1.html
-

-
Atg7是在自噬過程形成自噬體的必需因子之一,與泛素樣蛋白Atg8以及Atg12結合形成的E1樣酶。另一方面有報道稱在以帕金森氏癥為首的神經變性疾病中存在自噬因子功能障礙。抗人Atg7,兔 Anti Human Atg7, Rabbit, 是針對Atg7的抗體。[查看]
-
http://m.baichuan365.com/Article/Anti-Human-Atg7_1.html
-

-
杰克遜實驗室(JAX)的研究人員現在發現,已知會增加一個人患糖尿病風險的DNA序列變化與胰腺細胞處理兩種不同分子壓力的能力有關。在有這些DNA變化的人身上,胰腺中產生胰島素的細胞在暴露于壓力和炎癥時可能更容易衰竭或死亡。[查看]
-
http://m.baichuan365.com/Article/cellmetabolismtnbfxj_1.html
-

-
抗Iba1, 兔源, 結合SPICA Dye(TM) 568, Anti Iba1, Rabbit, SPICA Dye(TM) 568-conjugated, 是在FUJIFILM Wako的熱銷抗體Anti Iba1, Rabbit(免疫細胞化學用)(產品編號:019-19741)基礎上,標記了Alexa Fluor(R) 568系列中新型高耐光橙色熒光染料SPICA Dye(TM) 568 (Excitation=556 nm, Emission=591 nm),可節省二抗的操作步驟。[查看]
-
http://m.baichuan365.com/Article/SPICA Dye_568_1.html
-

-
抗 Iba1,兔源,SPICA Dye(TM) 594偶聯,是一款用和光獨有的熒光染料SPICA Dye(TM) 594標記Anti-Iba1,Rabbit(產品編號:019-19741,免疫細胞化學用)的抗體。可省去二抗的檢測。[查看]
-
http://m.baichuan365.com/Article/SPICA_Dye594_1.html
-

-
LabAssay(TM) 甘油三酯檢測試劑盒 LabAssay(TM) Triglyceride wako 采用基于N-乙基-N-(2-羥基-3-磺丙基)-3,5-二甲氧基苯胺鈉(DAOS)的藍色顯色酶法。通過微孔板法,可檢測小鼠血清中甘油三酯的含量,亦可檢測人血清中的甘油三酯。[查看]
-
http://m.baichuan365.com/Article/LabAssay_Triglyceride_1.html
-

-
LabAssay(TM) 膽固醇檢測試劑盒 LabAssay(TM) Cholestrol,為基于N-乙基-N-(2-羥基-3-磺丙基)-3,5-二甲氧基苯胺鈉(DAOS)的藍色顯色酶法試劑。微孔板法可用于測定小鼠、人血清中的總膽固醇。[查看]
-
http://m.baichuan365.com/Article/LabAssay_Cholestrol_1.html
-

-
LabAssay(TM) 游離脂肪酸檢測試劑盒, LabAssay(TM) NEFA , 采用了基于酰基輔酶A合成酶(ACS)、酰基輔酶A氧化酶(ACOD)和3-甲基-N-乙基-N-(β-羥乙基)-苯胺(MEHA)的藍紫色顯色酶法。不可用于體外診斷。[查看]
-
http://m.baichuan365.com/Article/LabAssay_NEFA_1.html
-

-
脫落酸 Abscisic acid
-

-
十八烷基三甲基溴化銨(STAB)
-
![LabAssay Creatinine肌氨酸酐定量檢測試劑盒 [Jaffe’method] 研究用試劑 LabAssay Creatinine肌氨酸酐定量檢測試劑盒 [Jaffe’method] 研究用試劑](http://m.baichuan365.com/UploadFiles/Product/20150119154331_69766.png)
-
LabAssay Creatinine肌氨酸酐定量檢測試劑盒 [Jaffe’method] 研究用試劑
-

-
LabAssay(R) 葡萄糖檢測試劑盒(Mutarotase-GOD法)
-

-
Glycan Labeling Kits 多糖標記試劑盒
-

-
2-AB Labeled N-Glycans 2-AB標記N-多糖
-

-
2-AA標記N-多糖 2-AA Labeled N-Glycans
-

-
APTS Labeled N-Glycans APTS標記N-多糖
-

-
2-AB Labeled O-Glycans 2-AB標記O-多糖
-

-
Unlabeled N-Glycans 未標記N-多糖
-

-
2-AB多糖標記試劑盒
-

-
細胞活性(熒光)測試盒 CellQuanti-Blue Cell Viability Assay Kits (貨號:CQBL-048/CQBL-05K)
-

-
Labnet FastPette V2 電動移液器
-

-
Labnet Mini LabRoller 混合儀 H5500-230V
-

-
Labnet GyroMini 盤旋3-D混合儀, S0500-230V
-

-
Labnet Orbit 1000多功能數字振蕩器,S2030-1000-B-230V
-

-
Labnet Orbit 300多功能數字螺旋混合儀, S2030-300-B-230V
-

-
Labnet VX-200漩渦混合儀
-

-
Adipocyte FABP Human ELISA, 人脂肪細胞型脂肪酸結合蛋白Elisa
-

-
牛奶細菌污染度檢測試劑,Color Table
-

-
D-阿拉伯糖 D-Arabinose (貨號:107861)
-

-
L-阿拉伯糖 L-Arabinose (貨號:107865)
-

-
(R,S)-N-Nitrosoanabasine
-

-
(R,S)-N-Nitrosoanatabine
-

-
NAT, (R,S)-N-Nitrosoanatabine
-

-
NAB, (R,S)-N-Nitrosoanabasine
-

-
NAB-d4
-

-
rac-NAB-D-glucoside
-

-
Sodium Tetraborate Decahydrate
-

-
Tetraborate pH Standard Solution
-

-
Tetraborate pH Standard Solution
-

-
Lithium Tetraborate Anhydrous
-

-
Lithium Tetraborate Anhydrous
-

-
Nicotinic Acid Absorbance/Transmission Standard 6mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 6mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 12mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 12mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 18mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 18mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 24mg/l
-

-
Nicotinic Acid Absorbance/Transmission Standard 24mg/l
-

-
Lithium Tetraborate, type II
-

-
Lithium Tetraborate, Granules
-

-
Sodium Tetraborate
-

-
USP Reagent Water System Suitability Standard
-

-
0.5 mg/L C from USP Sucrose System Suitability Standard
-

-
0.5 mg/L C from USP 1,4-Benzoquinone System Suitability Standard
-

-
USP System Suitability Set Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
-

-
System Suitability Set to USP;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
-

-
System Suitability USP Set;2 x H2O,0.5 mg/L C Sucrose,0.5 mg/L C,C6H4O2,0.25 mg/L C NIST Sucrose
-

-
System Suitability Set to USP;Reagent H2O, 0.5 mg/L C Sucrose,0.5 mg/L C 1,4-Benzoquinone.40mlbtls
-

-
System Suitability Set to JP;Reagent H2O,0.5 mg/L C from Sodium Dodecylbenzene Sulfonate
-

-
USP Suitability Kit;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C from USP 1,4- C6H4O2
-

-
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
-

-
USP System Suitability Set,Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
-

-
USP System Suitability Set;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C from USP C6H4O2
-

-
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C from USP Sucrose,0.5 mg/L C C6H4O2.
-

-
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
-

-
USP System Suitability Set,2 x Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.
-

-
USP System Suitability Set,Reagent H2O,0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2
-

-
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C C6H4O2.
-

-
USP System Suitability Reagent; H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4-Benzoquinone
-

-
USP System Suitability Set, 500mL Bottles
-

-
USP System Suitability Kit;2 x Blanks,0.5 mg/L C USP Sucrose,0.5 mg/L C USP C6H4O2
-

-
USP System Suitability Kit;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C from USP 1,4- C6H4O2.
-

-
USP System Suitability;Reagent H2O,0.500 mg/L C USP Sucrose,0.500 mg/L C USP 1,4- C6H4O2.
-

-
USP System Suitability Set, Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4- C6H4O2.1Lbtls
-

-
USP System Suitability Kit;2 x Reagent H2O,0.5 mg/L CUSP Sucrose,0.500 mg/L C USP 1,4- C6H4O2.
-

-
System Suitability Set;Reagent H2O, 0.5 mg/L C USP Sucrose,0.5 mg/L C USP 1,4-Benzoquinone.1Lbtls
-

-
TOC Standard USP System Suitability Solution 1 4-Benzoquinone (0.5mg/L C)
-

-
TOC Standard USP System Suitability Solution 14-Benzoquinone (0.5mg/L C) acidified with HCl
-

-
TOC Standard USP System suitability Set: 1x RTOCW 1x RTOCRs 1x RTOCRss
-

-
TOC Standard Set (12 x USP System Suitability Sets Delivered at monthly intervals)
-

-
TOC Standard Set (2 x USP System Suitability Sets Delivered at 6 monthly intervals)
-

-
TOC Standard Set (260 x USP System Suitability Sets Delivered at 2 weekly intervals)
-

-
TOC Standard Set (4 x USP System Suitability Sets Delivered at 3 monthly intervals)
-

-
TOC Standard Set (52 x USP System Suitability Sets Delivered at 2 weekly intervals)
-

-
Heavy Metals (Cd, Cr, Pb) in ABS Resin-Iow Concentration Pellet
-

-
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-Low Concentration Disk
-

-
Heavy Metals (Cd, Cr, Pb) in ABS Resin-Iow Concentration Disk
-

-
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-Low Concentration Pellet
-

-
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-High Concentration Disk
-

-
Organic Pollutants in Japanese Seabass Tissue
-

-
Pesticides in Cabbage
-

-
Heavy Metals (Cd, Cr, Pb) in ABS Resin-high Concentration Pellet
-

-
Heavy Metals (Cd, Cr, Hg, Pb) in ABS Resin-high Concentration Pellet
-

-
Sucrose (Brix) Standard Stabilised 0%-1.332986
-

-
Sucrose (Brix) Standard Stabilised 0%-1.332986
-

-
Sucrose (Brix) Standard Stabilised 5%-1.340264
-

-
Sucrose (Brix) Standard Stabilised 5%-1.340264
-

-
Sucrose (Brix) Standard Stabilised 7%-1.343253
-

-
Sucrose (Brix) Standard Stabilised 7%-1.343253
-

-
Sucrose (Brix) Standard Stabilised 10%-1.347824
-

-
Sucrose (Brix) Standard Stabilised 10%-1.347824
-

-
Sucrose (Brix) Standard Stabilised 11.2%-1.349682
-

-
Sucrose (Brix) Standard Stabilised 11.2%-1.349682
-

-
Sucrose (Brix) Standard Stabilised 11.5%-1.350149
-

-
Sucrose (Brix) Standard Stabilised 11.5%-1.350149
-

-
Sucrose (Brix) Standard Stabilised 12.5%-1.35093
-

-
Sucrose (Brix) Standard Stabilised 12.5%-1.35093
-

-
Sucrose (Brix) Standard Stabilised 12%-1.350930
-

-
Sucrose (Brix) Standard Stabilised 12%-1.350930
-

-
Sucrose (Brix) Standard Stabilised 15%-1.355679
-

-
Sucrose (Brix) Standard Stabilised 15%-1.355679
-

-
Sucrose (Brix) Standard Stabilised 20%-1.363842
-

-
Sucrose (Brix) Standard Stabilised 20%-1.363842
-

-
Sucrose (Brix) Standard Stabilised 25%-1.372328
-

-
Sucrose (Brix) Standard Stabilised 25%-1.372328
-

-
Sucrose (Brix) Standard Stabilised 30%-1.381149
-

-
Sucrose (Brix) Standard Stabilised 30%-1.381149
-

-
Sucrose (Brix) Standard Stabilised 35%-1.390322
-

-
Sucrose (Brix) Standard Stabilised 35%-1.390322
-

-
Sucrose (Brix) Standard Stabilised 40%-1.39986
-

-
Sucrose (Brix) Standard Stabilised 40%-1.39986
-

-
Sucrose (Brix) Standard Stabilised 45%-1.409777
-

-
Sucrose (Brix) Standard Stabilised 45%-1.409777
-

-
Sucrose (Brix) Standard Stabilised 50%-1.420087
-

-
Sucrose (Brix) Standard Stabilised 50%-1.420087
-

-
Sucrose (Brix) Standard Stabilised 55%-1.43080
-

-
Sucrose (Brix) Standard Stabilised 55%-1.43080
-

-
Sucrose (Brix) Standard Stabilised 60%-1.441928
-

-
Sucrose (Brix) Standard Stabilised 60%-1.441928
-

-
Sucrose (Brix) Standard Stabilised 67.5%-1.459290
-

-
Refractive Index at 20℃-1.34325 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.34325 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.34782 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.34782 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.34968 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.34968 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.35015 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.35015 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.35171 Stabilised Sucrose
-

-
Refractive Index @20℃-1.35171 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.35093 Stabilised Sucrose
-

-
Refractive Index @20℃-1.35093 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.35568 Stabilised Sucrose
-

-
Refractive Index @20℃-1.35568 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.36384 Stabilised Sucrose
-

-
Refractive Index @20℃-1.36384 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.37233 Stabilised Sucrose
-

-
Refractive Index @20℃-1.37233 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.38115 Stabilised Sucrose
-

-
Refractive Index @20℃-1.38115 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.39032 Stabilised Sucrose
-

-
Refractive Index @20℃-1.39032 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.39986 Stabilised Sucrose
-

-
Refractive Index @20℃-1.39986 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.40978 Stabilised Sucrose
-

-
Refractive Index @20℃-1.40978 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.42009 Stabilised Sucrose
-

-
Refractive Index @20℃-1.42009 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.43080 Stabilised Sucrose
-

-
Refractive Index @20℃-1.43080 Stabilised Sucrose
-

-
Refractive Index at 20℃-1.44193 Stabilised Sucrose
-

-
Refractive Index @20℃-1.44193 Stabilised Sucrose
-

-
N-亞硝基假木賊堿 (NAB)
-

-
Hydrogen Peroxide 10% w/v stabilised
-

-
TISAB for wine analysis (Dir. 2676/90) for the fluoride determination by selective electrodes.
-

-
ABTS
-

-
DTAB;十二烷基三甲基溴化銨
-

-
CTAB;十六烷基三甲基溴化銨
-

-
TTAB;十四烷基三甲基溴化銨
-

-
十八烷基三甲基溴化銨(STAB)
-

-
Glycerol-3-phosphate Dehydrogenase,from rabbit muscle, suspension
-

-
L-Lactate Dehydrogenase (L-LDH)from rabbit muscle, suspension
-

-
Pyruvate Kinase,from rabbit muscle, suspension
-

-
Triose-phosphate Isomerase,from rabbit muscle, suspension
-

-
Pefabloc SC (AEBSF)
-

-
2,2'-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid (ABTS),solution
-

-
Ethyclozate metabolite (CIA:5-Chloro-3 (1H)-indazolacetate)
-

-
N-Nitrosoanatabine 2,4,5,6 D4, 10ng/ul 于丙酮
-

-
European Pharmacopoeia Reagent 0.1M Tetrabutylammonium Hydroxide
-

-
European Pharmacopoeia Reagent 0.1M Tetrabutylammonium Hydroxide in 2-propanol
-

-
EDDP perchlorate (Methadone metabolite),100ug/mL (as pyrolinium) 于甲醇
-

-
EDDP perchlorate (Methadone metabolite),1.0mg/mL (as pyrrolinium) 于甲醇
-

-
Gabapentin,1.0mg/mL 于甲醇
-

-
MABM-LJ738-IGG
-

-
MABM-TU11-IGG
-

-
MABM-TU2-IGG Carcinoembryonic antigen
-

-
MABM-TU3-IGG
-

-
MAB M-7.4.5 IGG
-

-
MAB M-6.12.47 IGG
-

-
Mab Mix creatinine kinase isoenzyme MM
-

-
MAB
- M-1.2.57 IgG
-

-
MAB
- M-2.1.16 IgG,Human fibrinogen cleavage product D-Dimer
-

-
MABM-3.170-IgG,Human liver ferritin
-

-
MABM-4.184-IgG
-

-
MABM-INN22-IgG Human chorionic gonadotropin b-chain
-

-
MABM-INN2-IgG
-

-
MABM-Tu66C7-IgG salivary α-amylase
-

-
MABM-Tu88E8-IgG
-

-
MABM-323-IgG
-

-
MABM-7H8-IGG
-

-
MABM-BM1-IgG
-

-
MABM-ST3-IgG
-

-
MABM-11412-IgG Luteinizing hormone
-

-
MABM-2.406-IgG
-

-
MABM-C4E4-IGG,Prolactin
-

-
MABM-H12G10-IGG
-

-
MABM-TU1.20-IGG
-

-
PABS-Ig,Human C-reactive protein
-

-
PABS-IGG,trijodothyronine
-

-
PABS-IGG